Related Experiment Video

Updated: Aug 11, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
10:19

A Murine Model of Group B Streptococcus Vaginal Colonization

Published on: November 16, 2016

Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis

Regina M Renner1, A Renner, Seraina Schmid

  • 1Department of Obstetrics and Gynecology, University Hospital, Basel, Switzerland.

Journal of Perinatal Medicine
|February 24, 2006
PubMed

Insights

Our new strategy for preventing early-onset Group B Streptococcus (GBS) sepsis in newborns, involving GBS screening and targeted intrapartum antibiotic prophylaxis (IAP), significantly reduced sepsis incidence. This approach is effective and cost-efficient compared to broader strategies.

Area of Science:

  • Neonatal Health
  • Infectious Disease Prevention
  • Obstetrics

Background:

  • Existing guidelines for preventing early-onset neonatal Group B Streptococcus (GBS) sepsis vary.
  • A new prevention strategy was developed in 1997, incorporating GBS screening at 36 weeks' gestation.
  • This strategy includes intrapartum antibiotic prophylaxis (IAP) for women with positive or unknown GBS colonization and at least one risk factor.

Purpose of the Study:

  • To evaluate the efficacy of the new prevention strategy for early-onset neonatal GBS sepsis.
  • To compare the incidence of GBS sepsis before and after the implementation of the new strategy.

Main Methods:

  • Retrospective study of early-onset GBS sepsis incidence among live births from 1997-2002.
  • Analysis of risk factors, GBS screening, and IAP in GBS sepsis cases.
  • Comparison with a historical cohort (1984-1993) that did not utilize GBS screening or routine IAP.

Main Results:

  • The incidence of early-onset GBS sepsis decreased from 1/1000 live births (G1) to 0.53/1000 live births (G2).
  • A significant reduction in overall intrapartum risk factors was observed in GBS sepsis cases.
  • The new strategy demonstrated a notable decrease in neonatal GBS sepsis rates.

Conclusions:

  • The implemented prevention strategy effectively reduces early-onset GBS sepsis in neonates.
  • The strategy is more cost-effective and has fewer associated complications than broader approaches like the CDC's strategy.
  • Targeted screening and IAP offer a beneficial approach to neonatal GBS sepsis prevention.
Abstract

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...